Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Supplement—May 2025
SUPPLEMENT ISSUE
Supplement
16S Ribosomal RNA Gene PCR and Sequencing for Pediatric Infection Diagnosis, United States, 2020–2023
Table 4
Comparison of conventional tests and 16S rRNA PCR and sequencing results from study of 16S ribosomal RNA gene PCR and sequencing for pediatric infection diagnosis, Mayo Clinic, Rochester, Minnesota, USA, 2020–2023*
Conventional tests characteristics | 16S rRNA PCR and sequencing results |
p value | |
---|---|---|---|
Positive | Negative | ||
Gram stain | |||
Positive | 7 | 0 | <0.0001 |
Negative |
26 |
119 |
|
Bacterial culture | |||
Positive | 14 | 9 | <0.0001 |
Negative |
19 |
119 |
|
BioFire Meningitis/Encephalitis panel, cerebrospinal fluid only | |||
Positive | 0 | 2† | 1.000 |
Negative |
2 |
19 |
|
Synovial fluid Kingella kingae PCR, when clinically ordered | |||
Positive | 3 | 0 | 0.143 |
Negative | 1 | 3 |
*Specimens were collected from same specimen source. †One panel was positive for parechovirus and another was positive for human herpesvirus 6.
Page created: April 11, 2025
Page updated: May 08, 2025
Page reviewed: May 08, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.